BAP1 Testing in Instance Choroidal Nevi or Uveal Melanoma

Status unconfirmed

Conditions studied: Choroidal Nevi, Uveal Melanoma

In brief

The BAP1 trial will examine the blood of patients diagnosed with choroidal nevi or uveal melanoma for a germline BAP1 mutation and other genetic markers associated with developing malignancy as well as additional sequencing of the uveal melanoma genome.

Key facts

Study ID

NCT01925599

Run by

Amy C Schefler, MD

People needed

133

Starts

2013-07-01

Expected to finish

2022-01-01

Last updated by the study team

2021-03-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• any person with choroidal nevi
• Willingness to provide signed informed consent
• Age > 18 years
• Diagnosis of choroidal nevi or uveal melanoma
• Threre are no exclusionary criteria for this study.

Where it is running

• Retina Consultants of Houston — Houston, Texas, United States
• Retina Consultants of Houston — Katy, Texas, United States
• Retina Consultants of Houston — The Woodlands, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.